
|Videos|May 10, 2018
Drug offers hope in treating ocular melanoma
Author(s)Richard Carvajal, MD
Richard Carvajal, MD, associate professor at Columbia University Medical Center, discusses one drug potential to treat ocular melanoma at ARVO 2018 in Honolulu.
Advertisement
The views expressed here belong to the author. They do not necessarily represent the views of Optometry Times or UBM Medica.
Richard Carvajal, MD, associate professor at Columbia University Medical Center, discusses one drug potential to treat ocular melanoma at ARVO 2018 in Honolulu.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
Johnson & Johnson invests $1B in ACUVUE contact lens manufacturing
2
Epion Therapeutics completes phase 3 trials of EpiSmart epithelium-on cross-linking for keratoconus
3
AOA 2026: Managing ocular toxicities in patients with cancer
4
Saptalis launches cyclosporine emulsion 0.05% for dry eye
5





















